Volume 58, Issue 1, Pages (July 2000)

Slides:



Advertisements
Similar presentations
Acid-base profile in patients on PD
Advertisements

A skeptical view of assisted home peritoneal dialysis
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Issue 2, Pages (October 2000)
Volume 66, Issue 6, Pages (December 2004)
Volume 54, Issue 2, Pages (August 1998)
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function  N. Rabbani, K. Sebekova, K. Sebekova, A.
Volume 68, Issue 6, Pages (December 2005)
Volume 57, Issue 6, Pages (June 2000)
Acid-base profile in patients on PD
Volume 58, Issue 4, Pages (October 2000)
Volume 56, Pages S54-S56 (July 1999)
D. Teta, M. Maillard, G. Halabi, M. Burnier  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Volume 67, Issue 2, Pages (February 2005)
Volume 59, Issue 1, Pages (January 2001)
Volume 68, Issue 6, Pages (December 2005)
Volume 62, Issue 4, Pages (October 2002)
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis
Volume 57, Issue 2, Pages (October 2000)
Volume 59, Issue 6, Pages (June 2001)
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Volume 66, Issue 2, Pages (August 2004)
Volume 63, Issue 1, Pages (January 2003)
Volume 59, Issue 5, Pages (May 2001)
M. Svensson, H. Irjala, C. Svanborg, G. Godaly  Kidney International 
Volume 64, Issue 5, Pages (November 2003)
E. Boulanger, N. Grossin, M.-P. Wautier, R. Taamma, J.-L. Wautier 
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
What really happens to people on long-term peritoneal dialysis?
Magnus Åbrink, Eric Larsson, Anders Gobl, Lars Hellman 
Volume 86, Issue 6, Pages (December 2014)
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Blood pressure targets in hemodialysis patients
Volume 62, Issue 2, Pages (August 2002)
Volume 65, Issue 6, Pages (June 2004)
Volume 72, Issue 12, Pages (December 2007)
In vitro biocompatibility performance of Physioneal
Volume 76, Issue 6, Pages (September 2009)
Volume 66, Issue 1, Pages (July 2004)
Volume 68, Issue 3, Pages (September 2005)
Volume 56, Issue 6, Pages (December 1999)
Volume 73, Pages S34-S41 (April 2008)
Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model  Siska Mortier, Dirk Faict, Norbert.
Volume 66, Issue 3, Pages (September 2004)
Volume 60, Issue 6, Pages (December 2001)
Volume 64, Issue 5, Pages (November 2003)
Lipid-binding proteins in rat and human kidney
Nitric oxide inhibits the formation of advanced glycation end products
Volume 63, Issue 6, Pages (June 2003)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 61, Issue 2, Pages (February 2002)
A skeptical view of assisted home peritoneal dialysis
Volume 60, Issue 2, Pages (August 2001)
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes  Sr. Anne B. Bakewell, Rob M. Higgins, Mair.
Volume 58, Issue 1, Pages (July 2000)
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 2, Pages (February 2003)
Sclerosing encapsulating peritonitis in a 47-year-old woman
Volume 63, Issue 1, Pages (January 2003)
Biocompatibility of icodextrin
Volume 80, Issue 10, Pages (November 2011)
Volume 64, Issue 1, Pages (July 2003)
Volume 57, Issue 2, Pages (October 2000)
Volume 54, Issue 4, Pages (October 1998)
Volume 65, Issue 1, Pages (January 2004)
The International Pediatric Peritonitis Registry: Starting to walk
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Presentation transcript:

Volume 58, Issue 1, Pages 425-435 (July 2000) Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds  Toshio Miyata, Katsunori Horie, Yasuhiko Ueda, Yuji Fujita, Yuko Izuhara, Hiroshi Hirano, Koji Uchida, Akira Saito, Charles Van Ypersele De Strihou, Kiyoshi Kurokawa  Kidney International  Volume 58, Issue 1, Pages 425-435 (July 2000) DOI: 10.1046/j.1523-1755.2000.00182.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Representative high-pressure liquid chromatography (HPLC) chromatograms of peritoneal dialysis (PD) fluids and effluents. (A) Standards of glyoxal (GO), methylglyoxal (MGO), and 3-deoxyglucosone (3-DG). (B) The filter-sterilized PD fluid. (C) The commercial heat-sterilized PD fluid, and (D) the PD effluents after a 12-hour dwell time. PD fluids contained a 1.36% glucose. DNPH is the derivatizing agent and RCO-2,4-dinitrophenylhydrazone is the compound after reaction. Details are in the Methods section. GO, MGO, and 3-DG formed during the heat-sterilization are major RCOs in the PD fluids (C). Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Levels of GO (A), MGO (B), and 3-DG (C) in filter- and heat-sterilized PD fluids (glucose concentrations: 1.36, 2.27, 3.86%; N = 3, each) and in PD effluents (original glucose concentration, 1.36%, N = 3) after overnight dialysis. The heat-sterilized PD fluids contain a significant amount of GO, MGO, and 3-DG. By contrast, their concentrations in the filter-sterilized PD fluids are extremely low. Their concentrations in the PD effluents are significantly lower (P < 0.0001) than in the heat-sterilized PD fluids. Data are expressed as mean ± SD. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Kinetics of clearance of RCOs during PD. The concentrations of GO (A), MGO (B), and 3-DG (C) are determined in triplicates in PD effluents (original glucose concentration of PD fluid, 1.36%) collected from 12-hour dwells of the PD patient. Their concentrations are decreased with increasing dwell time. Data from three PD patients are expressed as mean ± SD. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Total RCO contents in PD fluids (N = 3), PD effluents after a 12-hour dwell time (N = 14) and in PD plasma (N = 14). Original glucose level of PD effluents was 1.36%. Samples were incubated with DNPH, followed by the determination of RCOs (other than glucose) content by a spectrophotometric assay. Samples processed similarly but without DNPH treatment were used as blanks. Total RCO content in PD effluent ultrafiltrates is much higher than those in the filter- and heat-sterilized PD fluids. It increases with increasing dwell time and tends to reach levels observed in plasma ultrafiltrate. Data are expressed as mean ± SD. *P < 0.001 compared with filter-sterilized PD fluids; ‡P < 0.01 compared with heat-sterilized PD fluids. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Generation of pentosidine in PD fluids, PD effluents, and in PD plasma (N = 3, each; A) and the kinetics of pentosidine generation during dialysis (B). The contents of pentosidine generated upon incubation of PD fluids, PD effluent (after a 12-hour dwell) ultrafiltrates, and PD plasma ultrafiltrates, fortified with BSA were determined by HPLC assay. The PD fluid glucose concentration is 1.36%. In some experiments, incubations were performed in the presence of aminoguanidine or OPB-9195 (final concentrations, 50 mmol/L). The amount of pentosidine generated during incubation of PD effluent (after a 12-hour dwell) ultrafiltrates is significantly higher than that of the filter- and heat-sterilized PD fluids: It increases with increasing dwell time and tends to reach levels observed after incubation of plasma ultrafiltrate. Data are expressed as means ± SD. *P < 0.001 compared with filter-sterilized PD fluids; ‡P < 0.005 compared with heat-sterilized PD fluids; **P < 0.01 compared with filter-sterilized PD fluids; §P < 0.05 compared with heat-sterilized PD fluids; NS, not significant. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Immunohistochemical detection of AGEs and ALEs in peritoneal tissues from PD patients. Peritoneal tissue sections from a 65-year-old patient on hemodialysis (group I in Table 1; A) and from a 52-year-old patient on PD for 117 months (group III; B–F) were stained with hematoxylin and eosin (B) or immunostained for CML (A and C), pentosidine (D), MDA-lysine (E), and HNE-protein adduct (F). Nuclei were counterstained with Meyer's hematoxylin. The staining for AGEs and ALEs was faint in hemodialysis patients not undergoing PD (A). AGE and ALE stainings were strongly positive in the mesothelial layers and vascular walls of the peritoneal tissue of patients on long-term PD (C–F). Note that the distributions of AGEs and ALEs were identical. A–F ×200. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Immunohistochemical detection of AGEs and ALEs in peritoneal tissues from PD patients. Peritoneal tissue sections from a 65-year-old patient on hemodialysis (group I in Table 1; A) and from a 52-year-old patient on PD for 117 months (group III; B–F) were stained with hematoxylin and eosin (B) or immunostained for CML (A and C), pentosidine (D), MDA-lysine (E), and HNE-protein adduct (F). Nuclei were counterstained with Meyer's hematoxylin. The staining for AGEs and ALEs was faint in hemodialysis patients not undergoing PD (A). AGE and ALE stainings were strongly positive in the mesothelial layers and vascular walls of the peritoneal tissue of patients on long-term PD (C–F). Note that the distributions of AGEs and ALEs were identical. A–F ×200. Kidney International 2000 58, 425-435DOI: (10.1046/j.1523-1755.2000.00182.x) Copyright © 2000 International Society of Nephrology Terms and Conditions